DLGAP5 and pancreatic neoplasm: Previous articles determined that DLGAP5 overexpression had also been shown in lung cancer, breast cancer, pancreatic cancer, endometrial cancer, and colorectal cancer (Shi et al., 2017; Branchi et al., 2019; Ke et al., 2020; Xu et al., 2020; Zhang et al., 2020).